Novo’s oral amycretin could lead to more weight loss beyond 12 weeks, according to early-stage trial

Pick what newsletters get delivered to your inbox each week.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 3:30 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET

POST-HOC 1-2 times a week

Healthcare

ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET

BREAKING NEWS ALERTS 2-3 times a week

Prime Medicine receives FDA clearance to run first prime editing clinical trial

The FDA has OK’d the first-ever human trial of prime editing, Prime Medicine announced Monday, opening the door for testing a new technology that backers

April 30, 2024

Cresco Labs Q4 Revenue Declines

Cresco Labs Reports Fourth Quarter & Full Year 2023 Financial Results Demonstrating Significant Profitability and Cash Flow Improvements Continued execution of Year-of-the-Core strategy delivers strong

March 13, 2024

Doctors Facing Discipline for COVID Misinfo Sue State Medical Board

Four doctors are suing the Washington Medical Commission, challenging the state licensing body’s position statement on COVID-19 misinformation. Three of the doctors hold active licenses

August 10, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.